Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia

AIM: Matrix metalloproteinase‐9 (MMP‐9) has been shown to modulate synaptic plasticity and may contribute to the pathophysiology of schizophrenia. This study investigated the peripheral levels of MMP‐9 and its association with cognitive functions in patients with schizophrenia to see the possible in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudo, Noriko, Yamamori, Hidenaga, Ishima, Tamaki, Nemoto, Kiyotaka, Yasuda, Yuka, Fujimoto, Michiko, Azechi, Hirotsugu, Niitsu, Tomihisa, Numata, Shusuke, Ikeda, Manabu, Iyo, Masaomi, Ohmori, Tetsuro, Fukunaga, Masaki, Watanabe, Yoshiyuki, Hashimoto, Kenji, Hashimoto, Ryota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722656/
https://www.ncbi.nlm.nih.gov/pubmed/32022478
http://dx.doi.org/10.1002/npr2.12098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722656/
https://www.ncbi.nlm.nih.gov/pubmed/32022478
http://dx.doi.org/10.1002/npr2.12098

Ejemplares similares